Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Viropin Pharmaceutical works in Biotechnology Research, out of Dunedin, Otago. Ownership is privately held; it publishes at viropin.com. It holds one address on record, all in New Zealand. The record counts 4 people. The record links four similar brands, most of them in Construction.
Viropin's Mission is to pioneer a future where infectious diseases are anticipated and neutralised before they threaten humanity.
The world is on the verge of a microbial apocalypse with the rise in drug-resistant microbes.
Viropin has a 3-prong approach to disease control:
1. Surveillance via proprietary AI tech.
2. Diagnostics via VariantVault, a cutting-edge microbe library.
3. Treatment of drug-resistant microbes with proprietary sterilants, decolonizers and anti-viral products.
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, New Zealand only. Primary: 8 Stafford St, Dunedin, Otago 9016.
None linked to this brand.
Four peer profiles on record: Topline Carpenters Ltd and Zestt Wellness.